Alkermes reports 30% rise in sales of key drug
Company pulls full-year guidance on coronavirus disruption to healthcare systems
Company pulls full-year guidance on coronavirus disruption to healthcare systems
Company reports 21% rise in sales to $1.09bn and reduced losses in 2018
Advisory panel votes down opioid-based drug on concerns over safety and efficacy
Food and Drug Administration accepts filing from Irish pharma group fortnight after refusal
US regulator says more clinical trials needed before considering Irish drug group’s depression treatment
Irish-domiciled biopharma group reported 31% rise in sales last year
Heavy investment in R&D and set-up costs for new therapies push biopharma group to $30.6m loss
Company drops development of new pain therapy after missing targets in Phase 1 trial
Dublin-based pharma group says it’s not in line for takeover driven by Ireland’s low tax regime
Company will seek US marketing approval for long-acting injectible aripiprazole lauroxil
Biopharma group bullish on prospects for pipeline and existing portfolio this year
An inspired approach to clinical trial data is fuelling the firm’s assault on central nervous system ailments
Group of investment firms looking at investment opportunities in Europe
Company brings fiscal year in line with calendar
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices